Article
CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer
20 Dec 2010
Abstract excerpt
Lung cancer is the most common cause of cancer-related death worldwide. Current investigations in the field of cancer research have intensively focused on the 'cancer stem cell' or 'tumor-initiating cell'. While CD133 was initially considered as a stem cell marker only in the hematopoietic system and the nervous system, the membrane antigen also identifies tumorigenic cells in certain solid tumors. In this study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
